Edition:
United States

Diffusion Pharmaceuticals Inc (DFFN.OQ)

DFFN.OQ on NASDAQ Stock Exchange Capital Market

0.22USD
3:59pm EST
Change (% chg)

$0.02 (+7.60%)
Prev Close
$0.20
Open
$0.20
Day's High
$0.22
Day's Low
$0.19
Volume
93,007
Avg. Vol
47,278
52-wk High
$2.08
52-wk Low
$0.19

Chart for

About

Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC)... (more)

Overall

Beta: -1.45
Market Cap(Mil.): $14.69
Shares Outstanding(Mil.): 50.64
Dividend: --
Yield (%): --

Financials

  DFFN.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -0.45 -- --
ROI: -78.11 0.60 13.80
ROE: -155.53 -2.18 15.29

Earnings vs. Estimates